Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

ClinicalTrials.gov ID: NCT04575935

Public ClinicalTrials.gov record NCT04575935. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 4, 2026, 12:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy

Study identification

NCT ID: NCT04575935
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: M.D. Anderson Cancer Center; Other
Enrollment: 580 participants

Conditions and interventions

Conditions

Interventions

Chemotherapy Drug
Laparotomy Procedure
Minimally Invasive Surgery Procedure
Quality-of-Life Assessment Other
Questionnaire Administration Other

Drug · Procedure · Other

Eligibility (public fields only)

Age range: 18 Years and older
Sex: Female
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 4, 2020
Primary completion: Dec 30, 2028
Completion: Dec 30, 2028
Last update posted: Mar 4, 2026

2020 – 2028

United States locations

U.S. sites: 13
U.S. states: 8
U.S. cities: 10

Facility	City	State	ZIP	Site status
University of Miami Miller School of Medicine-Sylvester Cancer Center	Miami	Florida	33136	Recruiting
Cleveland Clinic Foundation - Florida	Weston	Florida	33331	Recruiting
Massachusetts General Hospital	Boston	Massachusetts	02114	Recruiting
Dana Farber Cancer Institute	Boston	Massachusetts	02215	Recruiting
NYU Langone Health	Mineola	New York	11501	Recruiting
Columbia University Medical Center	New York	New York	10032	Recruiting
Duke	Durham	North Carolina	27710	Recruiting
Cleveland Clinic	Cleveland	Ohio	44195	Recruiting
St. Luke's University Health Network	Bethlehem	Pennsylvania	18015	Recruiting
Lyndon Baines Johnson General	Houston	Texas	77026	Recruiting
Houston Methodist	Houston	Texas	77030	Recruiting
M D Anderson Cancer Center	Houston	Texas	77030	Recruiting
University of Wisconsin Carbone Cancer Center	Madison	Wisconsin	53792	Active, not recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04575935, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 4, 2026 · Synced May 4, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04575935 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →